Crowdonomics
Myosana Therapeutics, Inc.

Reg CF · SAFE · Nov 2025

OpenReached targetReg CFSAFE
via WeFunder · last checked Oct 8, 2026View campaign
Raised
$561.2K / $1.2M max
45% of ceiling · target hit day 279
Investors
55
$10.2K avg
Momentum
$2K/day
best $10K · 204 days left

Raised over time

Cumulative raisedInvestors
$561K$281K$0
55280
Nov 13, 2025 · openedOct 8, 2026 · latest
Target ($50K) hit — Aug 19, 2026, day 279Deadline Apr 30, 2027 — 204 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder, last checked Oct 8, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2023–FY2024 · hover for source
$0
−$1.4M
FY2023
$0
−$1.6M
FY2024
RevenueNet income
Metric
FY2023 reviewed
FY2024 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$1,409,570
-$1,573,691
Taxes paid
$0
$0
Balance sheet
Cash
$992,171
$695,125
Accounts receivable
$0
$36,241
Total assets
$4,137,388
$2,229,084
Short-term debt
$507,058
$105,558
Long-term debt
$0
$0
Total liabilities
$507,058
$105,558
Other
Headcount
—
0

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Apr 28, 2026
    • Deadline Apr 30, 2026 → Apr 30, 2027

    “Adding 2025 financials and extending”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Valuation cap$27.4M

Offering details

Target$50,000
Max$1,235,000
Min investment—
OpenedNov 13, 2025
DeadlineApr 30, 2027
Days active329
Days to deadline204

Links & provenance

Source: SEC EDGAR
0001955277-25-000002
Last synced Oct 8, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.